Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells - PubMed (original) (raw)
Effects of angiotensin II receptor antagonist, Losartan on the apoptosis, proliferation and migration of the human pancreatic stellate cells
Wen-Bin Liu et al. World J Gastroenterol. 2005.
Abstract
Aim: To investigate the effects of AT1 (Type 1 angiotensin II receptor) antagonist (Losartan) on the apoptosis, proliferation and migration of the human pancreatic stellate cells (hPSCs).
Methods: hPSCs were isolated from pancreatic sample of patients with pancreatic carcinoma using radioimmunoassay (RIA) technique to detect the concentration of AngII in culture media and cell homogenate. Immunocytochemistry (ICC) and in situ hybridization (ISH) methods were utilized to test AT1 expression in hPSCs. Effects of Losartan on hPSCs proliferation, apoptosis and migration were investigated using BrdU incorporation, TUNEL, flow cytometry (FCM), and phase-contrast microscope separately when cells treated with Losartan. Immunofluorescence and Western blot were applied to quantify the expression of type I collagen in hPSCs.
Results: There exists AT1 expression in hPSCs, while no AngII was detected in culture media and cell homogenate. Losartan induces cell apoptosis in a dose- and time-dependent manner (apparently at 10(-5) mol/L), no pro-proliferative effect was observed in the same condition. Corresponding dosage of Losartan can also alleviate the motion capability and type I collagen content of hPSCs compared with AngII treatment and non-treatment control groups.
Conclusion: These findings suggest that paracrine not autocrine functions of AngII may have effects on hPSCs, which was mediated by AT1 expressed on cells, while Losartan may exert anti-fibrotic effects by inhibiting hPSCs motion and partly by inducing apoptosis.
Figures
Figure 1
Immunocytochemistry and ISH detection of AT1 in hPSCs at protein and mRNA levels. Immunostaining positive particles were located in plasm, A (magnification ×100); B (magnification ×400). ISH positive signals were located in nuclei C (magnification ×100); D (magnification ×400).
Figure 2
Dose-dependent induction of apoptosis by Losartan at different concentrations. (Con, 1 = 10-9, 2 = 10-7 , 3 = 10-5, 4 = 10-3 mol/L; a_P_ < 0.05 vs different from all groups ).
Figure 3
Time-course of Losartan-induced apoptosis. hPSCs in 0.1% FCS were exposed to 10-5 mol/L Losartan, and was assessd at 24, 48,72 h. Results indicate that Losartan induces apoptosis in a time-dependent manner.
Figure 4
Effects of Losartan on hPSCs proliferation assessed with BrdU incorporation. Losartan itself did not affect cell proliferation compared to control group. (a_P_>0.05 different from all the groups).
Figure 5
AngII accelerates in vitro wound healing confluent, culture-activated PSCs were serum deprived for 48 h. A wound was produced in the monolayer with a pipette tip, and the cells were exposed to (A) AngII (10-8 mol/L), (B) 10% fetal bovine serum, (C) AngII + Losartan, (D) serum-free medium along 24 h later, the cells were photographed.
Figure 6
Losartan down-regulated collagen I protein expression by western blot and immunofluoresence. hPSCs were incubated with 10-6 mol/L Losartan. Samples were exposed to certain concentration of Losartan+AngII and AngII for 24 h.
Similar articles
- Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro.
Zhao Y, Peng J, Zheng L, Yu W, Jin J. Zhao Y, et al. Prostate. 2010 Jun 1;70(8):899-905. doi: 10.1002/pros.21124. Prostate. 2010. PMID: 20135646 - The Angiotensin II Type 1 Receptor Antagonist Losartan Affects NHE1-Dependent Melanoma Cell Behavior.
Olschewski DN, Hofschröer V, Nielsen N, Seidler DG, Schwab A, Stock C. Olschewski DN, et al. Cell Physiol Biochem. 2018;45(6):2560-2576. doi: 10.1159/000488274. Epub 2018 Mar 16. Cell Physiol Biochem. 2018. PMID: 29558744 - Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II.
Galindo M, Santiago B, Palao G, Gutierrez-Cañas I, Ramirez JC, Pablos JL. Galindo M, et al. Peptides. 2005 Sep;26(9):1647-53. doi: 10.1016/j.peptides.2005.02.024. Peptides. 2005. PMID: 16112405 - Effects of angiotensin II and losartan on the growth and proliferation of hepatic stellate cells.
Zhang YJ, Yang XS, Wu PS, Li X, Zhang XF, Chen XQ, Yu ZX. Zhang YJ, et al. Di Yi Jun Yi Da Xue Xue Bao. 2003 Mar;23(3):219-21, 227. Di Yi Jun Yi Da Xue Xue Bao. 2003. PMID: 12651233 - Mesangial AT1 receptors: expression, signaling, and regulation.
Ardaillou R, Chansel D, Chatziantoniou C, Dussaule JC. Ardaillou R, et al. J Am Soc Nephrol. 1999 Jan;10 Suppl 11:S40-6. J Am Soc Nephrol. 1999. PMID: 9892139 Review.
Cited by
- Losartan enhances the suppressive effect of pirfenidone on the bleomycin-induced epithelial-mesenchymal transition and oxidative stress in A549 cell line.
Amirkhosravi A, Heidari MR, Karami-Mohajeri S, Torshabi M, Mandegary A, Mehrabani M. Amirkhosravi A, et al. Iran J Basic Med Sci. 2023;26(8):972-978. doi: 10.22038/IJBMS.2023.68982.15035. Iran J Basic Med Sci. 2023. PMID: 37427320 Free PMC article. - Drug Repurposing, an Attractive Strategy in Pancreatic Cancer Treatment: Preclinical and Clinical Updates.
De Lellis L, Veschi S, Tinari N, Mokini Z, Carradori S, Brocco D, Florio R, Grassadonia A, Cama A. De Lellis L, et al. Cancers (Basel). 2021 Aug 5;13(16):3946. doi: 10.3390/cancers13163946. Cancers (Basel). 2021. PMID: 34439102 Free PMC article. Review. - Molecular mechanisms of pancreatic myofibroblast activation in chronic pancreatitis and pancreatic ductal adenocarcinoma.
Cannon A, Thompson CM, Bhatia R, Armstrong KA, Solheim JC, Kumar S, Batra SK. Cannon A, et al. J Gastroenterol. 2021 Aug;56(8):689-703. doi: 10.1007/s00535-021-01800-4. Epub 2021 Jul 19. J Gastroenterol. 2021. PMID: 34279724 Free PMC article. Review. - Impact of Angiotensin Receptor Blockers, Beta Blockers, Calcium Channel Blockers and Thiazide Diuretics on Survival of Ovarian Cancer Patients.
Cho MA, Jeong SY, Sohn I, Kim MS, Kang JH, Paik ES, Lee YY, Choi CH. Cho MA, et al. Cancer Res Treat. 2020 Apr;52(2):645-654. doi: 10.4143/crt.2019.509. Epub 2020 Jan 16. Cancer Res Treat. 2020. PMID: 32019281 Free PMC article. - Utilizing cell line-derived organoids to evaluate the efficacy of a novel LIFR-inhibitor, EC359 in targeting pancreatic tumor stroma.
Hall BR, Cannon A, Thompson C, Santhamma B, Chavez-Riveros A, Bhatia R, Nair HB, Nickisch K, Batra SK, Kumar S. Hall BR, et al. Genes Cancer. 2019 Feb;10(1-2):1-10. doi: 10.18632/genesandcancer.184. Genes Cancer. 2019. PMID: 30899415 Free PMC article.
References
- Valderrama R, Navarro S, López JM, Caballería J, Giménez A, Parés A, Adrián MJ, Fernández-Cruz L, Terés J. Synthesis and degradation of collagen in pancreatic fibrogenesis. Pancreas. 1999;18:34–38. - PubMed
- Wang XP, Zhang R, Wu K, Wu L, Dong Y. Angiotensin II mediates acinar cell apoptosis during the development of rat pancreatic fibrosis by AT1R. Pancreas. 2004;29:264–270. - PubMed
- Bachem MG, Schneider E, Gross H, Weidenbach H, Schmid RM, Menke A, Siech M, Beger H, Grünert A, Adler G. Identification, culture, and characterization of pancreatic stellate cells in rats and humans. Gastroenterology. 1998;115:421–432. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials